Liquid capsule external application patch for treating hysteromyoma
Through the multi-layer structure design of liquid capsule external application patch, the problem of unstable effect of traditional Chinese medicine external application in the treatment of uterine fibroids is solved, the durability and comfort of the drug effect are improved, and the use process is simplified.
Patent Information
- Application Number
- CN202421552188.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-03
- Publication Date
- 2025-07-22
- Estimated Expiration
- 2034-07-03
AI Technical Summary
The existing traditional Chinese medicine external application for the treatment of uterine fibroids has the problem that the individualized effect is difficult to quantify, resulting in unstable treatment effect.
A multi-layer structure liquid capsule external application patch is designed, including an adhesive layer, a sponge layer, a mineral heating layer, a breathable layer and a plant fiber surface layer. By setting up a liquid release cavity between the sponge layer and the plant fiber surface layer, the liquid is adsorbed by the sponge layer and spread evenly after the liquid capsule is damaged, combining with the mineral heating layer to promote drug absorption.
It improves the durability and stability of the efficacy, enhances the patient's comfort, and improves the therapeutic effect through uniform diffusion and acupuncture administration, while simplifying the use process.
Smart Images

Figure CN223126919U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to the technical field of external application patches, in particular to a liquid capsule external application patch for treating uterine fibroids. Background Technique
[0002] Uterine fibroids are common benign tumors in women. Traditional Chinese medicine usually treats uterine fibroids by taking traditional Chinese medicine orally, applying externally, acupuncture, and diet therapy. In traditional Chinese medicine theory, it is believed that uterine fibroids are mostly related to factors such as emotional injury, improper diet, and overwork, which lead to qi stagnation, blood stasis obstruction, and phlegm dampness endogenous, thus forming masses. Pathologically, fibroids may cause symptoms such as uterine enlargement, irregular menstruation, and pain.
[0003] Uterine fibroids belong to the categories of "Zhengjia", "Shijia", and "Changtan" in traditional Chinese medicine. They are caused by blood stasis condensing in the uterine cavity and stagnating in the thoroughfare and conception vessels. Traditional Chinese medicine treatment adopts the methods of regulating the thoroughfare and conception vessels, promoting blood circulation to remove blood stasis, and softening hard masses and dissipating nodules. Commonly used traditional Chinese medicines include drugs for promoting blood circulation to remove blood stasis, drugs for softening hard masses and dissipating nodules, and drugs for regulating menstruation and relieving pain, such as Guizhi Fuling Pills, Salvia miltiorrhiza, Red Peony Root, Sparganium stoloniferum, and Curcuma zedoaria. The external application drugs are formulated with pangolin, rhubarb, Sparganium stoloniferum, Curcuma zedoaria, etc., ground into powder, and applied externally to the abdomen to play a therapeutic role through skin penetration. The defect of the existing traditional Chinese medicine external application treatment plan is that the differences in the conditions and constitutions of different patients may lead to individualization of the treatment effect, and sometimes the effect is difficult to quantitatively evaluate. Therefore, it is particularly important to develop an external application product with better, excellent, and stable effects. Summary of the Invention
[0004] To solve the above technical problems, the utility model provides a liquid capsule external application patch for treating uterine fibroids. To have a basic understanding of some aspects of the disclosed embodiments, a simple summary is given below. This summary part is not a general review, nor is it intended to identify key / important constituent elements or delineate the protection scope of these embodiments. Its sole purpose is to present some concepts in a simple form as a preface to the subsequent detailed description.
[0005] The utility model adopts the following technical solutions:
[0006] Provide a liquid capsule external application patch for treating uterine fibroids. The liquid capsule external application patch is a multi-layer structure; the multi-layer structure is successively a bonding layer, a sponge layer for adsorbing liquid medicine, and a plant fiber surface layer from the bonding side;
[0007] A number of liquid medicine release cavities are arranged between the sponge layer and the plant fiber surface layer. The orifice of the liquid medicine release cavity is covered and sealed by the plant fiber surface layer. A liquid capsule is arranged in the liquid medicine release cavity, and the outer capsule wall of the liquid capsule is attached to the sponge layer.
[0008] Further, the liquid capsule external application patch for treating uterine fibroids further comprises: a mineral heating layer; the mineral heating layer is disposed between the sponge layer and the adhesive layer.
[0009] Further, the liquid capsule external application patch for treating uterine fibroids further comprises: a breathable layer; the breathable layer is disposed between the mineral heating layer and the adhesive layer.
[0010] Further, the liquid capsule external application patch for treating uterine fibroids further comprises: a protective layer; the protective layer is disposed on the surface of the adhesive layer.
[0011] Further, the protective layer, the plant fiber surface layer and the breathable layer have the same size; the mineral heating layer and the sponge layer have the same size; the area of the sponge layer is smaller than that of the plant fiber surface layer.
[0012] Beneficial effects brought by the present utility model:
[0013] Multi-layer structure design: The liquid capsule external application patch adopts a multi-layer structure, including an adhesive layer, a sponge layer and a plant fiber surface layer. The optimization of the materials and layout of each layer improves the stability of the product and the persistence of the medicinal effect.
[0014] Arrangement of liquid capsules: A number of liquid capsules are arranged between the sponge layer and the plant fiber surface layer. In this way, when the capsule wall of the liquid capsule is damaged, the medicinal liquid can be adsorbed by the sponge layer, thereby realizing the effective release and utilization of the medicinal liquid.
[0015] Adsorption of medicinal liquid: When the capsule wall of the liquid capsule is damaged, the sponge layer can quickly adsorb the medicinal liquid in the liquid capsule, enabling the medicinal liquid to continuously penetrate into the affected area, thereby improving the treatment effect.
[0016] Improve patient comfort: The plant fiber surface layer has good moisture absorption and sweat discharge performance, skin-friendly property, and breathability, which can keep the skin dry, thereby improving the comfort of the patient.
[0017] Convenient to use: The design of the liquid capsule external application patch is convenient for patients to use, and while ensuring the treatment effect, it improves the quality of life of the patients. Description of the drawings
[0018] In order to more clearly illustrate the technical solutions in the embodiments of the present utility model or the prior art, the following will briefly introduce the drawings required for the description of the embodiments or the prior art. Obviously, the drawings in the following description are only some embodiments of the present utility model. For those of ordinary skill in the art, without creative efforts, other drawings can also be obtained based on these drawings.
[0019] Figure 1It is a cross-sectional schematic diagram of a liquid capsule external application patch for treating uterine fibroids in this application. Specific embodiments
[0020] The embodiments of the present utility model will be described in detail below with reference to the accompanying drawings. It should be clear that the described embodiments are only a part of the embodiments of the present utility model, rather than all of the embodiments. All other embodiments obtained by those of ordinary skill in the art based on the embodiments of the present utility model without creative efforts belong to the scope of protection of the present utility model.
[0021] As Figure 1 shown, a liquid capsule external application patch for treating uterine fibroids is disclosed. The liquid capsule external application patch is a multi-layer structure. Among them, the multi-layer structure is, in order from the bonding side, a protective layer 1, a bonding layer 2, a breathable layer 3, a mineral heating layer 4, a sponge layer 5 for adsorbing liquid medicine, and a plant fiber surface layer 6. Herein, the bonding side refers to the side where the liquid capsule external application patch is attached to the clothing, that is, the side away from the body surface.
[0022] Between the sponge layer 5 and the plant fiber surface layer 6, a number of liquid capsules 8 are arranged.
[0023] The plant fiber surface layer 6 is a knitted fabric woven from one or more fibers such as long-staple cotton fiber, bamboo original fiber, and mulberry silk. The plant fiber surface layer 6 has good moisture absorption and sweat discharge performance, is more skin-friendly, breathable, and soft and comfortable, and can keep the skin dry. The protective layer 1, the plant fiber surface layer 6, and the breathable layer 3 have the same size, that is, the same shape contour and the same area size. The plant fiber surface layer 6 and the breathable layer 3 can be thermally pressed and combined into one by an existing composite machine.
[0024] The sponge layer 5 and the mineral heating layer 4 have the same size and the same area size. The size of the sponge layer 5 is smaller than that of the plant fiber surface layer 6, that is, the area of the sponge layer 5 is smaller than that of the plant fiber surface layer 6, so that the sponge layer 5 and the mineral heating layer 4 can be completely enclosed between the plant fiber surface layer 6 and the breathable layer 3 to avoid leakage of the liquid medicine and the heating substance.
[0025] A number of liquid medicine release cavities 7 are provided between the sponge layer 5 and the plant fiber surface layer 6. The orifice of the liquid medicine release cavity 7 is covered and sealed by the plant fiber surface layer 6, thereby forming a number of independent liquid medicine holding spaces. A liquid capsule 8 is arranged in the liquid medicine release cavity 7, and the outer capsule wall of the liquid capsule 8 is attached to the sponge layer 5, so that when the capsule wall of the liquid capsule 8 is damaged, the liquid medicine in the liquid capsule 8 is adsorbed by the sponge layer 5.
[0026] Specifically, a groove is hot-pressed in the center of the water-absorbing sponge through a constant-temperature nylon hot-rolling roller. This groove serves as the liquid medicine release cavity 7, and the shape of the groove matches that of the liquid capsule 8. The liquid capsule 8 is placed in the groove of the water-absorbing sponge through a negative-pressure feeding mechanism. Preferably, the number of hot-pressed grooves can be one, and the number of liquid capsules 8 is also set to one accordingly, or the number of grooves is multiple, distributed on the sponge layer 5 as required, and one liquid capsule 8 is placed in each groove.
[0027] The mineral heating layer 4 is used for heating and temperature raising, which not only accelerates the volatilization of liquid medicine molecules but also accelerates local blood circulation to promote the absorption of liquid medicine. The mineral heating layer 4 can adopt the existing technical structure. For example, the mineral heating layer is made of non-woven fabric wrapped with iron powder. When the iron powder contacts oxygen, it undergoes oxidation and releases heat, thus playing the role of heating up. Specifically, in addition to iron powder, it can also include vermiculite, activated carbon, inorganic salts, water, etc., which are not specifically limited here, and those skilled in the art can select suitable heating materials according to the actual situation.
[0028] The adhesive layer 2 is scraped and coated on the breathable layer 3. The adhesive layer 2 can be selectively arranged in strips at intervals on the breathable layer 3, preferably five strips. The protective layer 1 undergoes a composite process and is composite on the adhesive layer 2 to play a protective role and at the same time be used to isolate air.
[0029] A rubber ring 501 is provided on the side of the sponge layer 5 that fits with the plant fiber surface layer 6. The rubber ring 501 is arranged around the orifice of the liquid medicine release cavity 7, and the rubber ring 501 is bonded to the plant fiber surface layer 6.
[0030] The structural design of multiple independent liquid medicine holding spaces can ensure that the liquid medicine released from the liquid capsule 8 in the liquid medicine release cavity 7 can quickly and evenly diffuse into the sponge layer 5, rather than directly pouring into the space between the sponge layer 5 and the plant fiber surface layer 6 and staying on the surface of the sponge layer 5 for a short time, resulting in a large amount of liquid medicine directly impacting and contacting the skin, causing discomfort during the initial use. In this application, when the liquid medicine is adsorbed by the sponge layer 5, it gradually acts on the skin through the plant fiber surface layer 6, and plays a therapeutic role through the way of drug volatilization and transdermal drug delivery. The liquid capsule external application patch of this application can ensure that the liquid medicine acts on the skin to the greatest extent, that is, improve the utilization rate of the liquid medicine, and at the same time can also take into account the comfort during use, avoid drug waste, and also avoid the discomfort caused by the rapid influx of drugs.
[0031] In addition, the usage method of the liquid capsule external application patch of this application is relatively simple and convenient. After tearing off the protective layer 1, it can be directly applied to the underwear so that the drug molecules act on the perineum point. At the same time, the structural design of the liquid capsule external application patch of this application is more reasonable, the liquid medicine is better preserved, and it is also more convenient to use at any time.
[0032] Among them, the liquid capsule 8 is filled with a liquid medicine, which includes: a traditional Chinese medicine extract, vegetable oil, an active agent, and a penetration enhancer; wherein, by mass percentage, the traditional Chinese medicine extract is 40%-60%, the vegetable oil is 30%-70%, the active agent is 0.1%, and the penetration enhancer is 0.5%-2%. When the capsule wall of the liquid capsule 8 is damaged by an external force, the liquid medicine in the liquid capsule 8 is adsorbed by the sponge layer 5.
[0033] The liquid medicine in the liquid capsule includes a traditional Chinese medicine extract prepared from the following raw materials: Saussurea involucrata, Ligusticum chuanxiong, Curcuma zedoaria, Salvia miltiorrhiza, Chinese yam, Citrus medica, Frankincense, Myrrh, Curcuma longa, Rosa rugosa, Sappanwood, Trogopterus dung, Benzoin, Typha angustifolia, Ecklonia kurome.
[0034] During use, the patient first applies an external force to the liquid capsule 8 by squeezing, pressing, etc., so that the outer wall of the liquid capsule is damaged, and the liquid medicine in the liquid capsule 8 is then absorbed by the sponge layer 5. Due to the porous structure in the sponge layer 5, the liquid medicine will quickly spread throughout the sponge layer 5. The drug molecules pass through the plant fiber surface layer 6 and, at the same time, based on the methods of acupoint and transdermal drug delivery, enable the drug to enter from the surface to the inside through the skin pores, slowly release the drug molecules, and exert the drug effect.
[0035] The patient tears off the protective layer 1, exposes the adhesive layer 2, and applies the external application patch of the liquid capsule to the required acupoint, pain point, or other required skin area. During the application process, the mineral heating layer 4 undergoes an oxidation reaction and gradually heats up due to contact with oxygen, so that the blood temperature at the application site is maintained at an elevated level during the application process, accelerating the blood flow rate, promoting absorption, and further increasing the efficacy by promoting the volatilization of the liquid medicine through heating.
[0036] The above is only the specific implementation manner of the present invention, but the protection scope of the present invention is not limited thereto. Any changes or substitutions that can be easily thought of by those skilled in the art within the technical scope disclosed by the present invention should be covered within the protection scope of the present invention. Therefore, the protection scope of the present invention should be subject to the protection scope of the claims.
Claims
1. A liquid capsule external application patch for treating uterine fibroids, characterized in that, The liquid capsule external application patch is of a multi-layer structure; the multi-layer structure is, in sequence from the adhering side, an adhesive layer, a sponge layer for adsorbing liquid medicine, and a plant fiber surface layer; A plurality of liquid medicine release cavities are arranged between the sponge layer and the plant fiber surface layer. The orifices of the liquid medicine release cavities are covered and sealed by the plant fiber surface layer. Liquid capsules are arranged in the liquid medicine release cavities, and the outer capsule walls of the liquid capsules are attached to the sponge layer.
2. The liquid capsule external application patch for treating uterine fibroids according to claim 1, wherein It further includes: A mineral heating layer; the mineral heating layer is arranged between the sponge layer and the adhesive layer.
3. The liquid capsule external application patch for treating uterine fibroids according to claim 2, wherein, It further includes: A breathable layer; the breathable layer is arranged between the mineral heating layer and the adhesive layer.
4. The liquid capsule external application patch for treating uterine fibroids according to claim 3, characterized in that, It further includes: A protective layer; The protective layer is arranged on the surface of the adhesive layer.
5. The liquid capsule external application patch for treating uterine fibroids according to claim 4, characterized in that, The protective layer, the plant fiber surface layer and the breathable layer have the same size; the mineral heating layer and the sponge layer have the same size; the area of the sponge layer is smaller than that of the plant fiber surface layer.